HYCOR Biomedical Inc and Roche announced the signing of a global distribution agreement of KOVA urinalysis products. As part of the agreement, Roche will distribute KOVA urinalysis plastics and controls products with its urinalysis tests and platforms worldwide for the next five years.

KOVA urinalysis controls are used to validate the performance of urine chemistry test strips and readers and to help focus microscopic sediment analysis. KOVA urinalysis controls are part of a complete line of urinalysis products that include specially engineered Glasstic slides and high quality sample tubes.

Source: HYCOR Biomedical Inc